MAC has CIR approval in France
We are delighted to announce that MAC Clinical Research has received approval for the French Research Tax Credit (Crédit d’impôt recherche, CIR) for Research and
February 14, 2024
We are delighted to announce that MAC Clinical Research has received approval for the French Research Tax Credit (Crédit d’impôt recherche, CIR) for Research and
Race Equality Week (5-11 February) is an annual UK-wide movement that unites hundreds of thousands of organisations and individuals to address the barriers to race
We are proud to announce that MAC Clinical Research has received a bronze medal from EcoVadis, the world’s most trusted provider of business sustainability ratings.
As society continues to address the complexities of mental health issues, the therapeutic use of psychedelics is becoming more widely accepted as a potential treatment
At MAC Clinical Research, we take our Corporate Social Responsibility (CSR) very seriously. Our commitment is multifaceted and extends throughout our organisation and beyond; into
As we come closer to the end of the year, I want to take the opportunity to reflect on 2023 and all that we have
At MAC, we consistently prioritise subject diversity in the trials we run and manage. We highly value this commitment and, by leveraging our distinctive grasp
With insight from Dr Abiramy Yogendran Menopause is a natural biological process that marks the end of a woman’s reproductive years and typically occurs, when
Last week we attended the PHUSE EU Connect 2023 conference in Birmingham from 5 to 8 November. The conference was an excellent opportunity to connect
At the beginning of November, our Vice President of Global Proposals, Jude Warburton attended AusBiotech 2023 in Brisbane, Australia. This conference is Australia’s largest Life